TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T05849	Gastrin/cholecystokinin type B receptor	D0L9GG	Alprazolam	Approved	2118	C17H13ClN4	308.8	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	D0U3LS	Triazolam	Approved	5556	C17H12Cl2N4	343.2	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B09DPO	Tert-butyl N-[(2R)-1-[(3R)-3-[[5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]methyl]-2,3-dihydroindol-1-yl]-4-methyl-1-oxopentan-2-yl]carbamate	Investigative	70687140	C35H39FN4O4	598.7	CC(C)C[C@H](C(=O)N1C[C@@H](C2=CC=CC=C21)CC3C(=O)NC4=CC=CC=C4C(=N3)C5=CC=CC=C5F)NC(=O)OC(C)(C)C	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B09TCP	N-(2-Oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-4-pentyl-benzamide	Investigative	14208263	C27H27N3O2	425.5	CCCCCC1=CC=C(C=C1)C(=O)NC2C(=O)NC3=CC=CC=C3C(=N2)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B0DOK9	N-[(3S)-5-(2-Fluorophenyl)-1-methyl-2-oxo-3H-1,4-benzodiazepin-3-yl]-4-pentylbenzamide	Investigative	14208273	C28H28FN3O2	457.5	CCCCCC1=CC=C(C=C1)C(=O)N[C@@H]2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4F)C	IC50 = 60000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B0FM2Y	Tert-butyl N-[3-(acetamidomethylsulfanyl)-1-[[5-(2-fluorophenyl)-1-methyl-2,3-dihydro-1,4-benzodiazepin-2-yl]methylamino]-1-oxopropan-2-yl]carbamate	Investigative	44359866	C28H36FN5O4S	557.7	CC(=O)NCSCC(C(=O)NCC1CN=C(C2=CC=CC=C2N1C)C3=CC=CC=C3F)NC(=O)OC(C)(C)C	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B0I2SA	(3S)-7-Chloro-3-(1H-indol-3-ylmethyl)-5-phenyl-1,3,4,5-tetrahydro-1,4-benzodiazepin-2-one	Investigative	15614763	C24H20ClN3O	401.9	C1=CC=C(C=C1)C2C3=C(C=CC(=C3)Cl)NC(=O)[C@@H](N2)CC4=CNC5=CC=CC=C54	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B0P9YM	N-(9H-beta-Carbolin-3-yl)-benzamide	Investigative	19754256	C18H13N3O	287.3	C1=CC=C(C=C1)C(=O)NC2=NC=C3C(=C2)C4=CC=CC=C4N3	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B17SPY	7-Chloro-3-naphthalen-1-ylmethyl-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one	Investigative	15614736	C26H19ClN2O	410.9	C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)CC4=CC=CC5=CC=CC=C54	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B1ADL7	Tert-butyl N-[(2S)-1-[(3R)-3-[[5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]methyl]-2,3-dihydroindol-1-yl]-4-methyl-1-oxopentan-2-yl]carbamate	Investigative	70689205	C35H39FN4O4	598.7	CC(C)C[C@@H](C(=O)N1C[C@@H](C2=CC=CC=C21)CC3C(=O)NC4=CC=CC=C4C(=N3)C5=CC=CC=C5F)NC(=O)OC(C)(C)C	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B1G4DN	4-Dimethylamino-N-[5-(2-fluoro-phenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-benzamide	Investigative	14208255	C24H21FN4O2	416.4	CN(C)C1=CC=C(C=C1)C(=O)NC2C(=O)NC3=CC=CC=C3C(=N2)C4=CC=CC=C4F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B1TF3U	1-N,1-N-Diethyl-4-N-[[5-(2-fluorophenyl)-1-methyl-2,3-dihydro-1,4-benzodiazepin-2-yl]methyl]-2-(trifluoromethyl)benzene-1,4-diamine	Investigative	44359841	C28H30F4N4	498.6	CCN(CC)C1=C(C=C(C=C1)NCC2CN=C(C3=CC=CC=C3N2C)C4=CC=CC=C4F)C(F)(F)F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B21POC	Tert-butyl N-[(2R)-1-[(3S)-3-[[5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]methyl]-2,3-dihydroindol-1-yl]-4-methyl-1-oxopentan-2-yl]carbamate	Investigative	118718805	C35H39FN4O4	598.7	CC(C)C[C@H](C(=O)N1C[C@H](C2=CC=CC=C21)CC3C(=O)NC4=CC=CC=C4C(=N3)C5=CC=CC=C5F)NC(=O)OC(C)(C)C	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B23SXR	N-[(3R)-1-Methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-4-pentylbenzamide	Investigative	14208310	C28H29N3O2	439.5	CCCCCC1=CC=C(C=C1)C(=O)N[C@H]2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4)C	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B2AQ3T	N',N'-Diethyl-N-[[5-(2-fluorophenyl)-1-methyl-2,3-dihydro-1,4-benzodiazepin-2-yl]methyl]methanediamine	Investigative	44359865	C22H29FN4	368.5	CCN(CC)CNCC1CN=C(C2=CC=CC=C2N1C)C3=CC=CC=C3F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B30CTM	1-(9H-beta-Carbolin-3-yl)-3-(4-chloro-phenyl)-urea	Investigative	44209152	C18H13ClN4O	336.8	C1=CC=C2C(=C1)C3=CC(=NC=C3N2)NC(=O)NC4=CC=C(C=C4)Cl	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B36MOT	3-(5-Chloropyrazin-2-ylaminomethyl)-5-(2-fluorophenyl)-1H-1,4-benzodiazepin-2(3H)-one	Investigative	44359840	C20H15ClFN5O	395.8	C1=CC=C2C(=C1)C(=NC(C(=O)N2)CNC3=CN=C(C=N3)Cl)C4=CC=CC=C4F	IC50 = 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B38OGA	3-[2-(1H-Indol-3-yl)ethylamino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one	Investigative	14208238	C25H22N4O	394.5	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NCCC4=CNC5=CC=CC=C54	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B39ILO	[1-(1-Carbamoyl-2-phenyl-ethylcarbamoyl)-2-(1H-indol-3-yl)-ethyl]-carbamic acid tert-butyl ester	Investigative	10072464	C25H30N4O4	450.5	CC(C)(C)OC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N	Ki = 70000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B3O5ZS	(R)-2-Amino-N-((R)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-3-phenylpropanamide	Investigative	44311988	C25H24N4O2	412.5	CN1C2=CC=CC=C2C(=N[C@H](C1=O)NC(=O)[C@@H](CC3=CC=CC=C3)N)C4=CC=CC=C4	IC50 = 55000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B42PZF	3,5-Dichloro-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-benzamide	Investigative	14208265	C22H15Cl2N3O2	424.3	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NC(=O)C4=CC(=CC(=C4)Cl)Cl	IC50 = 180000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B47QGV	(1-Methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-urea	Investigative	15637194	C17H16N4O2	308.33	CN1C2=CC=CC=C2C(=NC(C1=O)NC(=O)N)C3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B4FRJ3	3-Amino-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one	Investigative	15637150	C15H12FN3O	269.27	C1=CC=C2C(=C1)C(=NC(C(=O)N2)N)C3=CC=CC=C3F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B4OAB8	CCK-A Agonist 18	Investigative	10841112	C35H32N4O5	588.7	CC(C)N(C1=CC=C(C=C1)OC)C(=O)CN2C3=CC=CC=C3N(C(=O)C(C2=O)CC4=NOC5=CC=CC=C54)C6=CC=CC=C6	IC50 = 173780.08 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B4WT7X	Tert-butyl N-[(2R)-3-(1H-indol-3-yl)-1-oxo-1-[(2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)amino]propan-2-yl]carbamate	Investigative	14208198	C31H31N5O4	537.6	CC(C)(C)OC(=O)N[C@H](CC1=CNC2=CC=CC=C21)C(=O)NC3C(=O)NC4=CC=CC=C4C(=N3)C5=CC=CC=C5	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B4ZDH7	(3R)-7-Chloro-3-[(2-oxo-1,3-dihydroindol-3-yl)methyl]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one	Investigative	15167780	C24H18ClN3O2	415.9	C1=CC=C(C=C1)C2=N[C@@H](C(=O)NC3=C2C=C(C=C3)Cl)CC4C5=CC=CC=C5NC4=O	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B5IEJ0	(3R)-1-Ethyl-5-(2-fluorophenyl)-3-(1H-indol-3-ylmethyl)-3H-1,4-benzodiazepin-2-one	Investigative	15614818	C26H22FN3O	411.5	CCN1C2=CC=CC=C2C(=N[C@@H](C1=O)CC3=CNC4=CC=CC=C43)C5=CC=CC=C5F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B5MNF6	(1-[(3-[(2,3-Dihydro-2-oxo-5-phenyl-1,4-benzodiazepin-3-yl)methyl]-2,3-dihydro-1H-indol-1-yl) carbonyl]-3-methylbutyl]-carbamic acid-1,1-dimethylethyl ester	Investigative	21246577	C35H40N4O4	580.7	CC(C)CC(C(=O)N1CC(C2=CC=CC=C21)CC3C(=O)NC4=CC=CC=C4C(=N3)C5=CC=CC=C5)NC(=O)OC(C)(C)C	IC50 = 130000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B5QP7C	1-Methyl-3-[[(3S)-1-methyl-2,3-dihydroindol-3-yl]methyl]-5-phenyl-3H-1,4-benzodiazepin-2-one	Investigative	70684970	C26H25N3O	395.5	CN1C[C@H](C2=CC=CC=C21)CC3C(=O)N(C4=CC=CC=C4C(=N3)C5=CC=CC=C5)C	IC50 = 140000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B62WUH	N-(9H-beta-Carbolin-3-yl)-2-(1H-indol-3-yl)-acetamide	Investigative	19754257	C21H16N4O	340.4	C1=CC=C2C(=C1)C3=CC(=NC=C3N2)NC(=O)CC4=CNC5=CC=CC=C54	IC50 = 67000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B63DCV	(3S)-4-Amino-3-[[(2S)-5-amino-2-[[(2S)-3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]pentanoyl]amino]-4-oxobutanoic acid	Investigative	14728761	C25H36N6O7	532.6	CC(C)(C)OC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N	Ki = 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B64WVZ	Thiophene-3-carboxylic acid [5-(2-fluoro-phenyl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-ylmethyl]-amide	Investigative	15167799	C21H18FN3OS	379.5	C1C(N=C(C2=CC=CC=C2N1)C3=CC=CC=C3F)CNC(=O)C4=CSC=C4	IC50 = 74000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B6N3FB	N-[[5-(2-Fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]methyl]thiophene-3-carboxamide	Investigative	15614749	C21H16FN3O2S	393.4	C1=CC=C2C(=C1)C(=NC(C(=O)N2)CNC(=O)C3=CSC=C3)C4=CC=CC=C4F	IC50 = 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B79CKD	1-[(4R)-6-(2-Fluorophenyl)-4-(1H-indol-3-ylmethyl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl]-N,N-dimethylmethanamine	Investigative	13953698	C28H25FN6	464.5	CN(C)CC1=NN=C2N1C3=CC=CC=C3C(=N[C@@H]2CC4=CNC5=CC=CC=C54)C6=CC=CC=C6F	IC50 = 60000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B7F3XW	(5R)-4-Acetyl-5-(2-fluorophenyl)-1-methyl-3-[(1-methylindol-3-yl)methyl]-3,5-dihydro-1,4-benzodiazepin-2-one	Investigative	57394919	C28H26FN3O2	455.5	CC(=O)N1[C@H](C2=CC=CC=C2N(C(=O)C1CC3=CN(C4=CC=CC=C43)C)C)C5=CC=CC=C5F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B7FZ3Y	(E)-1-Methyl-5-phenyl-3-thiophen-3-ylmethylene-1,3-dihydro-benzo[e][1,4]diazepin-2-one	Investigative	15167794	C21H16N2OS	344.4	CN1C2=CC=CC=C2C(=N/C(=C\\C3=CSC=C3)/C1=O)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B7JQ2D	(3R)-3-Amino-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one	Investigative	7216757	C16H15N3O	265.31	CN1C2=CC=CC=C2C(=N[C@H](C1=O)N)C3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B7R8OT	(3S)-1-Methyl-3-[(cyclohexylcarbonyl)amino]-5-phenyl-1H-1,4-benzodiazepin-2(3H)-one	Investigative	14208283	C23H25N3O2	375.5	CN1C2=CC=CC=C2C(=N[C@@H](C1=O)NC(=O)C3CCCCC3)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B7V5SD	(3S)-3-[[2-[[(2S)-2-Acetamido-3-(1H-indol-3-yl)propanoyl]amino]-3-[4-[(2-chlorophenyl)carbamoylamino]phenyl]propanoyl]amino]-4-[[(2R)-1-amino-3-(4-methylphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid	Investigative	44306868	C43H45ClN8O8	837.3	CC1=CC=C(C=C1)C[C@H](C(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)C(CC2=CC=C(C=C2)NC(=O)NC3=CC=CC=C3Cl)NC(=O)[C@H](CC4=CNC5=CC=CC=C54)NC(=O)C	IC50 = 63095.73 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B7XU6J	Chembl356110	Investigative	14444013	C36H48N6O8	692.8	CC(C)C[C@H](CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)OC(C)(C)C	IC50 = 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B8KEP0	N-[[5-(2-Fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]methyl]-2-hydroxy-2-phenylacetamide	Investigative	44360216	C24H22FN3O2	403.4	C1C(N=C(C2=CC=CC=C2N1)C3=CC=CC=C3F)CNC(=O)C(C4=CC=CC=C4)O	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B8O9JK	3,3'-[Iminobis(methylene)]bis[5-(2-fluorophenyl)-1H-1,4-benzodiazepin-2(3H)-one]	Investigative	15614752	C32H25F2N5O2	549.6	C1=CC=C2C(=C1)C(=NC(C(=O)N2)CNCC3C(=O)NC4=CC=CC=C4C(=N3)C5=CC=CC=C5F)C6=CC=CC=C6F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B8PXF4	N-{1-[2-Tert-Butoxycarbonylamino-3-(1H-indol-3-yl)-propionylamino]-pentyl}-3-(3-phenyl-propionylamino)-succinamic acid	Investigative	44377587	C34H45N5O7	635.7	CCCC[C@H](NC(=O)[C@@H](CC1=CNC2=CC=CC=C21)NC(=O)OC(C)(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)CCC3=CC=CC=C3	IC50 = 110000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B9C8UL	(3R)-7-Chloro-3-(1H-indol-3-ylmethyl)-5-phenyl-1,3,4,5-tetrahydro-1,4-benzodiazepin-2-one	Investigative	15614762	C24H20ClN3O	401.9	C1=CC=C(C=C1)C2C3=C(C=CC(=C3)Cl)NC(=O)[C@H](N2)CC4=CNC5=CC=CC=C54	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	B9Z1YI	3-{[5-(2-Fluoro-phenyl)-1-methyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-2-ylmethyl]-amino}-3-phenyl-propionic acid methyl ester	Investigative	44359879	C27H28FN3O2	445.5	CN1C(CN=C(C2=CC=CC=C21)C3=CC=CC=C3F)CNC(CC(=O)OC)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BA6TP8	(3R)-4-[[(2R)-1-Amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[3-[[3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]-5-methylhexanoyl]amino]-4-oxobutanoic acid	Investigative	44366188	C36H48N6O8	692.8	CC(C)CC(CC(=O)N[C@H](CC(=O)O)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)OC(C)(C)C	IC50 = 50000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BA74JE	3-Amino-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one	Investigative	4259649	C15H13N3O	251.28	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)N	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BA7Y4K	(3R)-3-[[2-[[(2R)-2-Acetamido-3-(1H-indol-3-yl)propanoyl]amino]-3-[3-[(2-methylphenyl)carbamoylamino]phenyl]propanoyl]amino]-4-[[(2S)-1-amino-3-(4-methylphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid	Investigative	44306887	C44H48N8O8	816.9	CC1=CC=C(C=C1)C[C@@H](C(=O)N)NC(=O)[C@@H](CC(=O)O)NC(=O)C(CC2=CC(=CC=C2)NC(=O)NC3=CC=CC=C3C)NC(=O)[C@@H](CC4=CNC5=CC=CC=C54)NC(=O)C	IC50 = 50118.72 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BB5AI8	N-[(3S)-1-Methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-4-pentylbenzamide	Investigative	14208309	C28H29N3O2	439.5	CCCCCC1=CC=C(C=C1)C(=O)N[C@@H]2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4)C	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BC0K9R	[1-(2-Oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-ylcarbamoyl)-2-phenyl-ethyl]-carbamic acid tert-butyl ester	Investigative	44312041	C29H30N4O4	498.6	CC(C)(C)OC(=O)N[C@H](CC1=CC=CC=C1)C(=O)NC2C(=O)NC3=CC=CC=C3C(=N2)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BC5R8A	(3R)-1-Methyl-3-[(1-methylindol-3-yl)methyl]-5-phenyl-3H-1,4-benzodiazepin-2-one	Investigative	15167820	C26H23N3O	393.5	CN1C=C(C2=CC=CC=C21)C[C@@H]3C(=O)N(C4=CC=CC=C4C(=N3)C5=CC=CC=C5)C	IC50 = 67000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BCHK09	N-{1-[1-(2-Butoxycarbonyl-ethylcarbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-pentyl}-3-(3-phenyl-propionylamino)-succinamic acid	Investigative	44377487	C37H49N5O8	691.8	CCCC[C@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NCCC(=O)OCCCC)NC(=O)[C@H](CC(=O)O)NC(=O)CCC3=CC=CC=C3	IC50 = 81000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BD3JZ2	N-(2-Oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)-2,3-dihydro-1H-indole-2-carboxamide	Investigative	14208212	C24H20N4O2	396.4	C1C(NC2=CC=CC=C21)C(=O)NC3C(=O)NC4=CC=CC=C4C(=N3)C5=CC=CC=C5	IC50 = 110000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BDG7T4	(3R)-1-Benzyl-7-chloro-3-(1H-indol-3-ylmethyl)-5-phenyl-3H-1,4-benzodiazepin-2-one	Investigative	15614847	C31H24ClN3O	490	C1=CC=C(C=C1)CN2C3=C(C=C(C=C3)Cl)C(=N[C@@H](C2=O)CC4=CNC5=CC=CC=C54)C6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BDI2Q7	N-(2-Oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-4-propyl-benzamide	Investigative	14208261	C25H23N3O2	397.5	CCCC1=CC=C(C=C1)C(=O)NC2C(=O)NC3=CC=CC=C3C(=N2)C4=CC=CC=C4	IC50 = 80000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BE29VC	N-[5-(2-Fluoro-phenyl)-1-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-4-pentyl-benzamide	Investigative	10182876	C28H28FN3O2	457.5	CCCCCC1=CC=C(C=C1)C(=O)NC2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4F)C	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BE7Q1U	3-Amino-5-(2-fluoro-phenyl)-1-methyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one	Investigative	14423345	C16H14FN3O	283.3	CN1C2=CC=CC=C2C(=NC(C1=O)N)C3=CC=CC=C3F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BF53SN	(3R)-3-(1H-Indol-3-ylmethyl)-5-methyl-1,3-dihydro-1,4-benzodiazepin-2-one	Investigative	136067266	C19H17N3O	303.4	CC1=N[C@@H](C(=O)NC2=CC=CC=C12)CC3=CNC4=CC=CC=C43	IC50 = 80000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BFTY26	2-Chloro-N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide	Investigative	14208252	C23H18ClN3O2	403.9	CN1C2=CC=CC=C2C(=N[C@@H](C1=O)NC(=O)C3=CC=CC=C3Cl)C4=CC=CC=C4	IC50 = 130000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BG69FB	(3S)-1-Methyl-3-[(2-methylpropanoyl)amino]-5-phenyl-1H-1,4-benzodiazepin-2(3H)-one	Investigative	14208280	C20H21N3O2	335.4	CC(C)C(=O)N[C@@H]1C(=O)N(C2=CC=CC=C2C(=N1)C3=CC=CC=C3)C	IC50 = 73000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BGAY63	(3R)-7-Chloro-5-(2-chlorophenyl)-3-(1H-indol-3-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-2-one	Investigative	15167775	C24H17Cl2N3O	434.3	C1=CC=C2C(=C1)C(=CN2)C[C@@H]3C(=O)NC4=C(C=C(C=C4)Cl)C(=N3)C5=CC=CC=C5Cl	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BGDV59	(S)-N-((S)-1-Carbamoyl-2-phenyl-ethyl)-3-{[(S)-2-[(S)-3-(1H-indol-3-yl)-2-methylamino-propionylamino]-6-(3-o-tolyl-ureido)-hexanoyl]-methyl-amino}-succinamic acid	Investigative	44372327	C40H50N8O7	754.9	CC1=CC=CC=C1NC(=O)NCCCC[C@@H](C(=O)N(C)[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC	IC50 = 69200 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BGUS25	(Z)-1-Methyl-5-phenyl-3-thiophen-3-ylmethylene-1,3-dihydro-benzo[e][1,4]diazepin-2-one	Investigative	15167795	C21H16N2OS	344.4	CN1C2=CC=CC=C2C(=N/C(=C/C3=CSC=C3)/C1=O)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BH1OB6	(R)-4-Dicyclohexylcarbamoyl-4-[(1H-indole-2-carbonyl)-amino]-butyric acid benzyl ester	Investigative	44370505	C33H41N3O4	543.7	C1CCC(CC1)N(C2CCCCC2)C(=O)[C@H](CCC(=O)OCC3=CC=CC=C3)NC(=O)C4=CC5=CC=CC=C5N4	IC50 = 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BH5CL3	Benzyl 4-[[5-(2-fluorophenyl)-1-methyl-2,3-dihydro-1,4-benzodiazepin-2-yl]methylamino]-4-oxobutanoate	Investigative	44359881	C28H28FN3O3	473.5	CN1C(CN=C(C2=CC=CC=C21)C3=CC=CC=C3F)CNC(=O)CCC(=O)OCC4=CC=CC=C4	IC50 = 55000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BH7YB0	(4R)-6-(2-Fluorophenyl)-4-(1H-indol-3-ylmethyl)-1-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine	Investigative	13953696	C31H22FN5	483.5	C1=CC=C(C=C1)C2=NN=C3N2C4=CC=CC=C4C(=N[C@@H]3CC5=CNC6=CC=CC=C65)C7=CC=CC=C7F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BHE53Y	2-Fluoro-N-[5-(2-fluoro-phenyl)-1-methyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-2-ylmethyl]-benzamide	Investigative	20190195	C24H21F2N3O	405.4	CN1C(CN=C(C2=CC=CC=C21)C3=CC=CC=C3F)CNC(=O)C4=CC=CC=C4F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BHQ12O	3-Chloro-N-[1-(3,3-dimethylbutylamino)-5-(4-methylpiperazin-1-yl)-1,5-dioxopentan-2-yl]benzamide;hydrochloride	Investigative	45262990	C23H36Cl2N4O3	487.5	CC(C)(C)CCNC(=O)C(CCC(=O)N1CCN(CC1)C)NC(=O)C2=CC(=CC=C2)Cl.Cl	IC50 = 103800 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BHXY60	(7S)-7-[[(2S,3As,4S)-4-hydroxy-2-methyl-2-(2-methylpropyl)-1-oxo-3,3a-dihydroimidazo[1,2-a]indol-4-yl]methyl]-6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-dione	Investigative	44368454	C32H31N5O4	549.6	CC(C)C[C@]1(C(=O)N2[C@H](N1)[C@@](C3=CC=CC=C32)(C[C@H]4C5=NC6=CC=CC=C6C(=O)N5C7=CC=CC=C7C(=O)N4)O)C	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BI1LD2	N-(9H-beta-Carbolin-3-yl)-3-phenyl-propionamide	Investigative	44209154	C20H17N3O	315.4	C1=CC=C(C=C1)CCC(=O)NC2=NC=C3C(=C2)C4=CC=CC=C4N3	IC50 = 68000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BI6R8F	(4R)-6-(2-Fluorophenyl)-4-(1H-indol-3-ylmethyl)-1-(trichloromethyl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine	Investigative	13953694	C26H17Cl3FN5	524.8	C1=CC=C2C(=C1)C(=CN2)C[C@@H]3C4=NN=C(N4C5=CC=CC=C5C(=N3)C6=CC=CC=C6F)C(Cl)(Cl)Cl	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BJ2GF4	(3R)-4-(4-Chlorobenzoyl)-5-(2-fluorophenyl)-1-methyl-3-[(1-methylindol-3-yl)methyl]-3,5-dihydro-1,4-benzodiazepin-2-one	Investigative	15167773	C33H27ClFN3O2	552	CN1C=C(C2=CC=CC=C21)C[C@@H]3C(=O)N(C4=CC=CC=C4C(N3C(=O)C5=CC=C(C=C5)Cl)C6=CC=CC=C6F)C	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BJ6CF3	(3R)-1-(Cyclopropylmethyl)-5-(2-fluorophenyl)-3-(1H-indol-3-ylmethyl)-3H-1,4-benzodiazepin-2-one	Investigative	15614820	C28H24FN3O	437.5	C1CC1CN2C3=CC=CC=C3C(=N[C@@H](C2=O)CC4=CNC5=CC=CC=C54)C6=CC=CC=C6F	IC50 = 58000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BJ9KP3	4-Methyl-N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]pentanamide	Investigative	14208282	C22H25N3O2	363.5	CC(C)CCC(=O)N[C@@H]1C(=O)N(C2=CC=CC=C2C(=N1)C3=CC=CC=C3)C	IC50 = 130000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BKH2P1	1-Methyl-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one	Investigative	613843	C16H14N2O	250.29	CN1C(=O)CN=C(C2=CC=CC=C21)C3=CC=CC=C3	IC50 = 94000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BKU59P	(3R)-3-[(1-Benzylindol-3-yl)methyl]-7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one	Investigative	15614851	C32H26ClN3O	504	CN1C2=C(C=C(C=C2)Cl)C(=N[C@@H](C1=O)CC3=CN(C4=CC=CC=C43)CC5=CC=CC=C5)C6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BL41CZ	CCK-A Agonist 26	Investigative	10556460	C42H39N5O4	677.8	CC(C)N(C1=CC=C(C=C1)OC)C(=O)CN2C3=CC=CC=C3N(C(=O)C(C2=O)CC4=NN(C5=CC=CC=C54)CC6=CC=CC=C6)C7=CC=CC=C7	IC50 = 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BLJ8A7	3-[[(3S)-2,3-Dihydro-1H-indol-3-yl]methyl]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one	Investigative	70697518	C24H21N3O	367.4	C1[C@H](C2=CC=CC=C2N1)CC3C(=O)NC4=CC=CC=C4C(=N3)C5=CC=CC=C5	IC50 = 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BLMW82	(3S)-3-Amino-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one	Investigative	7216755	C16H15N3O	265.31	CN1C2=CC=CC=C2C(=N[C@@H](C1=O)N)C3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BLNT90	2-Chloro-N-(2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)benzamide	Investigative	5279123	C22H16ClN3O2	389.8	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NC(=O)C4=CC=CC=C4Cl	IC50 = 52000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BM5L6X	(3R)-7-Chloro-3-(1H-indol-3-ylmethyl)-5-phenyl-1,3-dihydro-1,4-benzodiazepine-2-thione	Investigative	15614802	C24H18ClN3S	415.9	C1=CC=C(C=C1)C2=N[C@@H](C(=S)NC3=C2C=C(C=C3)Cl)CC4=CNC5=CC=CC=C54	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BM6QG0	CCK antagonist synthetic 8	Investigative	15614807	C24H19N3O	365.4	C1=CC=C(C=C1)C2=N[C@@H](C(=O)NC3=CC=CC=C32)CC4=CNC5=CC=CC=C54	IC50 = 50000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BM7W4B	3,4-Dichloro-N-[1-(dipentylamino)-5-(4-methylpiperazin-1-yl)-1,5-dioxopentan-2-yl]benzamide;hydrochloride	Investigative	45262992	C27H43Cl3N4O3	578	CCCCCN(CCCCC)C(=O)C(CCC(=O)N1CCN(CC1)C)NC(=O)C2=CC(=C(C=C2)Cl)Cl.Cl	IC50 = 50000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BME5K4	N-(2-Oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-4-trifluoromethylsulfanyl-benzamide	Investigative	44311626	C23H16F3N3O2S	455.5	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NC(=O)C4=CC=C(C=C4)SC(F)(F)F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BMO2K4	(2R)-2-Amino-N-(2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)-3-phenylpropanamide	Investigative	44312020	C24H22N4O2	398.5	C1=CC=C(C=C1)C[C@H](C(=O)NC2C(=O)NC3=CC=CC=C3C(=N2)C4=CC=CC=C4)N	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BNT6J8	CCK-A Agonist 23	Investigative	10769902	C36H35N5O4	601.7	CC(C)N(C1=CC=C(C=C1)OC)C(=O)CN2C3=CC=CC=C3N(C(=O)C(C2=O)(C)CC4=C5C=CC=CC5=NN4)C6=CC=CC=C6	IC50 = 69183.1 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BO6G7A	3-(3-Benzyl-ureido)-N-{1-[1-(2-butoxycarbonyl-ethylcarbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-pentyl}-succinamic acid	Investigative	44377852	C36H48N6O8	692.8	CCCC[C@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NCCC(=O)OCCCC)NC(=O)[C@H](CC(=O)O)NC(=O)NCC3=CC=CC=C3	IC50 = 78000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BOSD23	1-(2-Amino-4-methyl-1-oxopentyl)-3-((2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)methyl)-2,3-dihydro-1H-indole hydrochloride	Investigative	20063239	C30H33ClN4O2	517.1	CC(C)CC(C(=O)N1CC(C2=CC=CC=C21)CC3C(=O)NC4=CC=CC=C4C(=N3)C5=CC=CC=C5)N.Cl	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BP4GR5	2-Amino-N-[5-(2-fluoro-phenyl)-1-methyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-2-ylmethyl]-3-(1H-indol-3-yl)-propionamide	Investigative	19766227	C28H28FN5O	469.6	CN1C(CN=C(C2=CC=CC=C21)C3=CC=CC=C3F)CNC(=O)C(CC4=CNC5=CC=CC=C54)N	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BP6V1X	N-[[5-(2-Fluorophenyl)-1-methyl-2,3,4,5-tetrahydro-1,4-benzodiazepin-2-yl]methyl]thiophene-3-carboxamide	Investigative	19766220	C22H22FN3OS	395.5	CN1C(CNC(C2=CC=CC=C21)C3=CC=CC=C3F)CNC(=O)C4=CSC=C4	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BPB1S7	(3R)-5-(2-Fluorophenyl)-3-(1H-indol-3-ylmethyl)-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepin-2-one	Investigative	15614826	C26H19F4N3O	465.4	C1=CC=C2C(=C1)C(=CN2)C[C@@H]3C(=O)N(C4=CC=CC=C4C(=N3)C5=CC=CC=C5F)CC(F)(F)F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BPDZ07	3-Aminomethyl-5-(2-fluorophenyl)-1H-1,4-benzodiazepin-2(3H)-one	Investigative	15614835	C16H14FN3O	283.3	C1=CC=C2C(=C1)C(=NC(C(=O)N2)CN)C3=CC=CC=C3F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BPHQ09	[2-(1H-Indol-3-yl)-1-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-ylcarbamoyl)-ethyl]-carbamic acid tert-butyl ester	Investigative	14208197	C31H31N5O4	537.6	CC(C)(C)OC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NC3C(=O)NC4=CC=CC=C4C(=N3)C5=CC=CC=C5	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BQ15CX	2-Chloro-N-methyl-N-(1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl)benzamide	Investigative	15167811	C24H20ClN3O2	417.9	CN1C2=CC=CC=C2C(=NC(C1=O)N(C)C(=O)C3=CC=CC=C3Cl)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BQ34DB	(3R)-5-(2-Fluorophenyl)-3-(1H-indol-3-ylmethyl)-1-pentyl-3H-1,4-benzodiazepin-2-one	Investigative	15614822	C29H28FN3O	453.5	CCCCCN1C2=CC=CC=C2C(=N[C@@H](C1=O)CC3=CNC4=CC=CC=C43)C5=CC=CC=C5F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BRE71N	2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-phenyl-3-(phenylmethyl)-, (R)-	Investigative	2794055	C22H17ClN2O	360.8	C1=CC=C(C=C1)C[C@@H]2C(=O)NC3=C(C=C(C=C3)Cl)C(=N2)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BRF10C	(3S)-1-Benzyl-7-chloro-3-(1H-indol-3-ylmethyl)-5-phenyl-3H-1,4-benzodiazepin-2-one	Investigative	15614848	C31H24ClN3O	490	C1=CC=C(C=C1)CN2C3=C(C=C(C=C3)Cl)C(=N[C@H](C2=O)CC4=CNC5=CC=CC=C54)C6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BRM18N	[5-(2-Fluoro-phenyl)-1-methyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-2-ylmethyl]-carbamic acid isobutyl ester	Investigative	19766222	C22H26FN3O2	383.5	CC(C)COC(=O)NCC1CN=C(C2=CC=CC=C2N1C)C3=CC=CC=C3F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BRY2C9	N-(2-Oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)pyrazine-2-carboxamide	Investigative	5279395	C20H15N5O2	357.4	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NC(=O)C4=NC=CN=C4	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BS0H6A	2-(Acetamidomethylsulfanyl)-N-[[5-(2-fluorophenyl)-1-methyl-2,3-dihydro-1,4-benzodiazepin-2-yl]methyl]acetamide	Investigative	44359880	C22H25FN4O2S	428.5	CC(=O)NCSCC(=O)NCC1CN=C(C2=CC=CC=C2N1C)C3=CC=CC=C3F	IC50 = 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BSQ9I3	N-[5-(2-Fluoro-phenyl)-1-methyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-2-ylmethyl]-nicotinamide	Investigative	20190196	C23H21FN4O	388.4	CN1C(CN=C(C2=CC=CC=C21)C3=CC=CC=C3F)CNC(=O)C4=CN=CC=C4	IC50 = 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BT16XW	(3R)-7-Chloro-5-phenyl-3-[(4-phenylmethoxyphenyl)methyl]-1,3-dihydro-1,4-benzodiazepin-2-one	Investigative	15167771	C29H23ClN2O2	467	C1=CC=C(C=C1)COC2=CC=C(C=C2)C[C@@H]3C(=O)NC4=C(C=C(C=C4)Cl)C(=N3)C5=CC=CC=C5	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BT5K1J	N-(2-Oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)-4-phenylbenzamide	Investigative	14208262	C28H21N3O2	431.5	C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)NC3C(=O)NC4=CC=CC=C4C(=N3)C5=CC=CC=C5	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BT6BZ7	N-[[(2R)-5-(4-Fluorophenyl)-1,8-dimethyl-2,3-dihydro-1,4-benzodiazepin-2-yl]methyl]-4-methylbenzamide	Investigative	44309988	C26H26FN3O	415.5	CC1=CC=C(C=C1)C(=O)NC[C@@H]2CN=C(C3=C(N2C)C=C(C=C3)C)C4=CC=C(C=C4)F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BU1ZY5	[5-(2-Fluoro-phenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-ylmethyl]-carbamic acid benzyl ester	Investigative	20063245	C24H20FN3O3	417.4	C1=CC=C(C=C1)COC(=O)NCC2C(=O)NC3=CC=CC=C3C(=N2)C4=CC=CC=C4F	IC50 = 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BU6B7D	2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-3-(1H-indol-3-ylmethyl)-5-phenyl-, (S)-	Investigative	39760	C24H18ClN3O	399.9	C1=CC=C(C=C1)C2=N[C@H](C(=O)NC3=C2C=C(C=C3)Cl)CC4=CNC5=CC=CC=C54	IC50 = 70000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BU7GB8	CCK antagonist synthetic 7	Investigative	15614850	C25H20ClN3O	413.9	CN1C2=C(C=C(C=C2)Cl)C(=N[C@@H](C1=O)CC3=CNC4=CC=CC=C43)C5=CC=CC=C5	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BU81CS	(3S)-5-(2-Fluorophenyl)-3-(1H-indol-3-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-2-one	Investigative	13822910	C24H18FN3O	383.4	C1=CC=C2C(=C1)C(=CN2)C[C@H]3C(=O)NC4=CC=CC=C4C(=N3)C5=CC=CC=C5F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BV19YU	(3S)-3-[[2-[[(2S)-2-Acetamido-3-(1H-indol-3-yl)propanoyl]amino]-3-[4-[(2-methylphenyl)carbamoylamino]phenyl]propanoyl]amino]-4-[[(2R)-1-amino-3-(4-methylphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid	Investigative	44306360	C44H48N8O8	816.9	CC1=CC=C(C=C1)C[C@H](C(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)C(CC2=CC=C(C=C2)NC(=O)NC3=CC=CC=C3C)NC(=O)[C@H](CC4=CNC5=CC=CC=C54)NC(=O)C	IC50 = 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BV85TY	5-(2-Fluoro-phenyl)-3-thiophen-3-yl-1,3-dihydro-benzo[e][1,4]diazepin-2-one	Investigative	15167772	C19H13FN2OS	336.4	C1=CC=C2C(=C1)C(=NC(C(=O)N2)C3=CSC=C3)C4=CC=CC=C4F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BVL60C	N-(9H-beta-Carbolin-3-yl)-4-chloro-benzamide	Investigative	19754254	C18H12ClN3O	321.8	C1=CC=C2C(=C1)C3=CC(=NC=C3N2)NC(=O)C4=CC=C(C=C4)Cl	IC50 = 72000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BVT7U8	3-(5-Fluoro-1H-indol-3-ylmethyl)-5-(2-fluoro-phenyl)-1,3-dihydro-benzo[e][1,4]diazepin-2-one	Investigative	15167785	C24H17F2N3O	401.4	C1=CC=C2C(=C1)C(=NC(C(=O)N2)CC3=CNC4=C3C=C(C=C4)F)C5=CC=CC=C5F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BW20MG	1-Methyl-1H-indole-2-carboxylic acid (9H-beta-carbolin-3-yl)-amide	Investigative	19754255	C21H16N4O	340.4	CN1C2=CC=CC=C2C=C1C(=O)NC3=NC=C4C(=C3)C5=CC=CC=C5N4	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BW52EC	3-{2-[2-Tert-Butoxycarbonylamino-3-(1H-indol-3-yl)-propionylamino]-4-methyl-pentanoylamino}-N-(1-carbamoylmethyl-2-phenyl-ethyl)-succinamic acid	Investigative	14444025	C36H48N6O8	692.8	CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)CC(=O)N)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)OC(C)(C)C	IC50 = 50000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BW8O7I	(R)-2-(2-Quinolinylcarbonylamino)-3-(1H-indol-3-yl)-N,N-dipentylpropanamide	Investigative	44341429	C31H38N4O2	498.7	CCCCCN(CCCCC)C(=O)[C@@H](CC1=CNC2=CC=CC=C21)NC(=O)C3=NC4=CC=CC=C4C=C3	IC50 = 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BWI58C	[5-(2-Fluoro-phenyl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-ylmethyl]-carbamic acid benzyl ester	Investigative	15167797	C24H22FN3O2	403.4	C1C(N=C(C2=CC=CC=C2N1)C3=CC=CC=C3F)CNC(=O)OCC4=CC=CC=C4	IC50 = 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BWOD27	N-[[5-(2-Fluorophenyl)-2,3-dihydro-1-methyl-1H-1,4-benzodiazepin-2-YL]methyl]phthalimide	Investigative	44153340	C25H20FN3O2	413.4	CN1C(CN=C(C2=CC=CC=C21)C3=CC=CC=C3F)CN4C(=O)C5=CC=CC=C5C4=O	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BWYD91	[5-(2-Fluoro-phenyl)-1-methyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-2-ylmethyl]-(3-trifluoromethyl-phenyl)-amine	Investigative	19766234	C24H21F4N3	427.4	CN1C(CN=C(C2=CC=CC=C21)C3=CC=CC=C3F)CNC4=CC=CC(=C4)C(F)(F)F	IC50 = 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BX54GD	3,3,3-Trifluoro-N-[5-(2-fluoro-phenyl)-1-methyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-2-ylmethyl]-2-methoxy-2-phenyl-propionamide	Investigative	19766230	C27H25F4N3O2	499.5	CN1C(CN=C(C2=CC=CC=C21)C3=CC=CC=C3F)CNC(=O)C(C4=CC=CC=C4)(C(F)(F)F)OC	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BXDF78	9H-Pyrido[3,4-b]indol-3-amine	Investigative	119537	C11H9N3	183.21	C1=CC=C2C(=C1)C3=CC(=NC=C3N2)N	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BY1X2C	(3R)-3-[[1-(4-Chlorobenzoyl)indol-3-yl]methyl]-5-(2-fluorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one	Investigative	15614834	C32H23ClFN3O2	536	CN1C2=CC=CC=C2C(=N[C@@H](C1=O)CC3=CN(C4=CC=CC=C43)C(=O)C5=CC=C(C=C5)Cl)C6=CC=CC=C6F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BY7D4F	3-(6-Fluoro-1H-indol-3-ylmethyl)-5-(2-fluoro-phenyl)-1,3-dihydro-benzo[e][1,4]diazepin-2-one	Investigative	15167787	C24H17F2N3O	401.4	C1=CC=C2C(=C1)C(=NC(C(=O)N2)CC3=CNC4=C3C=CC(=C4)F)C5=CC=CC=C5F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BY7T0Z	3-Benzyloxycarbonylamino-N-{1-[1-(2-butoxycarbonyl-ethylcarbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-pentyl}-succinamic acid	Investigative	44377488	C36H47N5O9	693.8	CCCC[C@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NCCC(=O)OCCCC)NC(=O)[C@H](CC(=O)O)NC(=O)OCC3=CC=CC=C3	IC50 = 75000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BZE3M9	N-[5-(2-Fluoro-phenyl)-1-methyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-2-ylmethyl]-2-hydroxy-2-phenyl-acetamide	Investigative	44360121	C25H24FN3O2	417.5	CN1C(CN=C(C2=CC=CC=C21)C3=CC=CC=C3F)CNC(=O)C(C4=CC=CC=C4)O	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	BZX7K8	7-Chloro-3-naphthalen-2-ylmethyl-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one	Investigative	15614737	C26H19ClN2O	410.9	C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)CC4=CC5=CC=CC=C5C=C4	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	D06DTT	RO-054520	Investigative	193319	C16H13FN2O	268.28	CN1C(=O)CN=C(C2=CC=CC=C21)C3=CC=CC=C3F	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	D0EZ2W	CR-2345	Investigative	45265542	C26H37Cl3N4O3	560	CN1CCN(CC1)C(=O)CCC(C(=O)N2CCC3(CCCC3)CC2)NC(=O)C4=CC(=CC(=C4)Cl)Cl.Cl	IC50 = 120500 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	D0J0CA	BETA-CCM	Investigative	107704	C13H10N2O2	226.23	COC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2	IC50 ~ 100000 nM	Poor binder
T05849	Gastrin/cholecystokinin type B receptor	D0M9GO	tifluadom	Investigative	115208	C22H20FN3OS	393.5	CN1C(CN=C(C2=CC=CC=C21)C3=CC=CC=C3F)CNC(=O)C4=CSC=C4	Ki ~ 100000 nM	Poor binder